Evidence map›Paper›PMID 34988541›Full record

ArticleJournal of mass spectrometry and advances in the clinical lab2022

Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory.

Joshua A Dubland

Open access · goldAbstract read
In one paragraph

Article in Journal of mass spectrometry and advances in the clinical lab, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Dysfunctional high-density lipoprotein: an updated review.Frontiers in cardiovascular medicine · 2025
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Joshua A DublandDepartment of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, BC, Canada.
University of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ion mobility spectrometry (IMS) is an analytical technique where ions are separated in the gas phase based on their mobility through a buffer gas in the presence of an electric field. An ion passing through an IMS device has a characteristic collisional cross section (CCS) value that depends on the buffer gas used. IMS can be coupled with mass spectrometry (MS), which characterizes an ion based on a mass-to-charge ratio (

Indexed as

CCS, collisional cross sectionClinical analysisCV, compensation voltageCVD, cardiovascular diseaseDG, diacylglycerolDMS, differential mobility spectrometryDTIMS, drift tube ion mobility spectrometryEV, elution voltageFAIMS, field asymmetric waveform ion mobility spectrometryFIA, flow injection analysisFTICR, fourier-transform ion cyclotron resonanceHDL, high-density-lipoproteinHRMS, high-resolution mass spectrometryIMS, ion mobility spectrometryIMS-MS, ion mobility spectrometry-mass spectrometryIon mobility spectrometryLC, liquid chromatographyLDL, low-density-lipoproteinLipidsLPC, lysophosphatidylcholineMALDI, matrix-assisted laser desorption/ionizationMass spectrometryMS, mass spectrometrym/z, mass-to-charge ratioNBS, newborn screeningPC, glycerophosphocholinePE, phosphatidylethanolaminePG, phosphatidylglycerolRF, radio frequencySLIM, structures for loss less ion manipulationsSM, sphingomyelinSV, separation voltageTG, triglycerideTIMS, trapped ion mobility spectrometryTOF, time-of-flightTWIMS, traveling wave ion mobility spectrometryVLDL, very-low-density lipoprotein

Identifiers

PMID34988541
PMCPMC8703053
OpenAlexW4200238983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.